Ono Pharmaceutical -2026-JPM.pdf

1、44th Annual J.P.Morgan Healthcare ConferenceJanuary 14,2026Introduction Corporate Overview Life Cycle Management of OPDIVO Impact of Deciphera Acquisition Valuable Products from Deciphera Acceleration of Pipeline DevelopmentKey for Future GrowthOutlook for the FutureToichi Takino,Ph.D.Representative

2、 Director,President and Chief Operating Officer1Information about pharmaceutical products(including products currently in development)included in this document is not intended to constitute an advertisement of medical advice.Forecasts and other forward-looking statements included in this document ar

3、e based on information currently available and certain assumptions that the Company deems reasonable.Actual performance and other results may differ significantly due to various factors.Such factors include,but are not limited to:2Forward-looking statements:Current assumptions:Risks and uncertaintie

4、s:No guarantee of outcomes:Official guidance:Product/market risks:Economic/industry risks:No obligation to update:This presentation contains forward-looking statements regarding the Companys future plans,strategies,and performance.These statements are based on current expectations,assumptions,and in

5、formation available to management at this time.Forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially.Forecasts,targets,and projections are not guarantees of future performance or achievement of stated goals.Official financial guidance sh

6、ould be referred to in accordance with relevant regulatory requirements and disclosures.Risks include,but are not limited to,product development challenges,regulatory approvals,market acceptance,and competition.Additional risks may arise from changes in economic conditions,currency fluctuations,and